Pterostilbene fluorescent probes as potential tools for targeting neurodegeneration in biological applications

References

• Alzheimer’s Disease International. World Alzheimer Report 2019 [Internet]. Available from: https://www.alz.co.uk/research/WorldAlzheimerReport2019.pdf.
   Google Scholar
• 2021 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement 2021;17:327–406.
   PubMed Web of Science ®Google Scholar
• Breijyeh Z, Karaman R. Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules 2020;25:5789.
   PubMed Web of Science ®Google Scholar
• Raza C, Anjum R, Shakeel NA. Parkinson’s disease: mechanisms, translational models and management strategies. Life Sci 2019;226:77–90.
   PubMed Web of Science ®Google Scholar
• Cappella M, Ciotti C, Cohen-Tannoudji M, Biferi MG. Gene therapy for ALS—a perspective. Int J Mol Sci 2019;20:4388.
   PubMedGoogle Scholar
• Ricci F, Bandello F, Navarra P, et al. Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches. Int J Mol Sci 2020;21:8242.
   PubMed Web of Science ®Google Scholar
• Canady VA. FDA approves first drug therapy for Alzheimer’s in 18 years. Mental Health Weekly 2021;31:3–4.
   Google Scholar
• Walsh S, Merrick R, Milne R, Brayne C. Aducanumab for Alzheimer’s disease? BMJ 2021;374:n1682.
   PubMedGoogle Scholar
• Aducanumab. EMBO Mol Med 2021;13:e14781.
   PubMedGoogle Scholar
• Andrade S, Ramalho MJ, Loureiro JA. Natural compounds for Alzheimer’s disease therapy: a systematic review of preclinical and clinical studies. Int J Mol Sci 2019;41:2313.
   Web of Science ®Google Scholar
• Ciccone L, Tonali N, Nencetti S, Orlandini E. Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design. J Enzyme Inhib Med Chem 2020;35:1145–62.
   PubMed Web of Science ®Google Scholar
• Bernardini S. Natural products for human health: an historical overview of the drug discovery approaches. Nat Prod Res. 2017;26:1–25.
   Google Scholar
• Ciccone L, Vandooren J, Nencetti S, Orlandini E. Natural marine and terrestrial compounds as modulators of matrix metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s disease. Pharmaceuticals 2021;14:86.
   Web of Science ®Google Scholar
• Ciccone L, Nencetti S, Socci S, Orlandini E. Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological induction. Neural Regen Res 2021;16:2353–8.
   PubMed Web of Science ®Google Scholar
• Carresi C, Scicchitano M, Scarano F, et al. The potential properties of natural compounds in cardiac stem cell activation: their role in myocardial regeneration. Nutrients 2021;13:275.
   PubMed Web of Science ®Google Scholar
• Li W, Sun K, Hu F, et al. Protective effects of natural compounds against oxidative stress in ischemic diseases and cancers via activating the Nrf2 signaling pathway: a mini review. J Biochem Mol Toxicol 2021;35:e22658.
   PubMed Web of Science ®Google Scholar
• Kamal M, Naz M, Jawaid T, Arif M. Natural products and their active principles used in the treatment of neurodegenerative diseases: a review. Orient Pharm Exp Med 2019;19:343–65.
   Web of Science ®Google Scholar
• Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Res 2018;7:1161.
   Google Scholar
• Ahmed T, Javed S, Javed S, et al. Resveratrol and Alzheimer’s disease: mechanistic insights. Mol Neurobiol 2017;54:2622–35.
   PubMed Web of Science ®Google Scholar
• Xia D, Sui R, Zhang Z. Administration of resveratrol improved Parkinson’s disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1/miR-129/SNCA signaling pathway. J Cell Biochem 2019;120:4942–51.
   PubMed Web of Science ®Google Scholar
• Chen J-Y, Zhu Q, Zhang S, et al. Resveratrol in experimental Alzheimer’s disease models: a systematic review of preclinical studies. Pharmacol Res 2019;150:104476.
   PubMed Web of Science ®Google Scholar
• Arbo BD, André-Miral C, Nasre-Nasser RG, et al. Resveratrol derivatives as potential treatments for Alzheimer’s and Parkinson’s disease. Front Aging Neurosci 2020;12:103.
   PubMed Web of Science ®Google Scholar
• Wang D, Ho L, Faith J, et al. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer’s disease β-amyloid oligomerization. Mol Nutr Food Res 2015;59:1025–40.
   PubMed Web of Science ®Google Scholar
• Moussa C, Hebron M, Huang X, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J Neuroinflammation 2017;14:1.
   PubMed Web of Science ®Google Scholar
• Fang X, Zhang J, Zhao J, Wang L. Effect of resveratrol combined with donepezil hydrochloride on inflammatory factor level and cognitive function level of patients with Alzheimer’s disease. J Healthc Eng 2022;2022:e9148650–e9148657.
   PubMed Web of Science ®Google Scholar
• Turner RS, Thomas RG, Craft S, Study F the ADC, et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 2015;85:1383–91.
   PubMed Web of Science ®Google Scholar
• Venditti I, Iucci G, Fratoddi I, et al. Direct conjugation of resveratrol on hydrophilic gold nanoparticles: structural and cytotoxic studies for biomedical applications. Nanomaterials 2020;10:1898.
   Web of Science ®Google Scholar
• Poulose SM, Thangthaeng N, Miller MG, Shukitt-Hale B. Effects of pterostilbene and resveratrol on brain and behavior. Neurochem Int 2015;89:227–33.
   PubMed Web of Science ®Google Scholar
• Estrela JM, Ortega A, Mena S, et al. Pterostilbene: biomedical applications. Crit Rev Clin Lab Sci 2013;50:65–78.
   PubMed Web of Science ®Google Scholar
• Kapetanovic IM, Muzzio M, Huang Z, et al. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 2011;68:593–601.
   PubMed Web of Science ®Google Scholar
• Kim H, Seo K-H, Yokoyama W. Chemistry of pterostilbene and its metabolic effects. J Agric Food Chem 2020;68:12836–41.
   PubMed Web of Science ®Google Scholar
• Wang P, Sang S. Metabolism and pharmacokinetics of resveratrol and pterostilbene. BioFactors 2018;44:16–25.
   PubMed Web of Science ®Google Scholar
• Riche DM, McEwen CL, Riche KD, et al. Analysis of safety from a human clinical trial with pterostilbene. J Toxicol 2013;2013:e463595.
   PubMedGoogle Scholar
• Lange KW, Li S. Resveratrol, pterostilbene, and dementia. BioFactors 2018;44:83–90.
   PubMed Web of Science ®Google Scholar
• Deng L, Li Y, Zhang X, et al. UPLC–MS method for quantification of pterostilbene and its application to comparative study of bioavailability and tissue distribution in normal and Lewis lung carcinoma bearing mice. J Pharm Biomed Anal 2015;114:200–7.
   PubMed Web of Science ®Google Scholar
• Liu Y, You Y, Lu J, et al. Recent advances in synthesis, bioactivity, and pharmacokinetics of pterostilbene, an important analog of resveratrol. Molecules 2020;25:5166.
   PubMed Web of Science ®Google Scholar
• Cherniack EP. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders. Br J Nutr 2012;108:794–800.
   PubMed Web of Science ®Google Scholar
• Chang J, Rimando A, Pallas M, et al. Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer’s disease. Neurobiol Aging 2012;33:2062–71.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu X, Luo J, et al. Pterostilbene attenuates astrocytic inflammation and neuronal oxidative injury after ischemia-reperfusion by inhibiting NF-κB phosphorylation. Front Immunol. 2019;10:2408.
   PubMed Web of Science ®Google Scholar
• Song Z, Han S, Pan X, et al. Pterostilbene mediates neuroprotection against oxidative toxicity via oestrogen receptor α signalling pathways. J Pharm Pharmacol 2015;67:720–30.
   PubMed Web of Science ®Google Scholar
• Yanagi M, Uchida N, Hamada H. Versatile synthetic route for resveratrol modification via amine functionalization. Nat Prod Commun 2019;14:1934578X1987621.
   Web of Science ®Google Scholar
• Komatsu S, Ohno K, Fujimura T. Binding assays using a benzofurazan-labeled fluorescent probe for estrogen receptor–ligand interactions. Chem Pharm Bull 2020;68:954–61.
   PubMed Web of Science ®Google Scholar
• Uchiyama S, Santa T, Okiyama N, et al. Fluorogenic and fluorescent labeling reagents with a benzofurazan skeleton. Biomed Chromatogr 2001;15:295–318.
   PubMed Web of Science ®Google Scholar
• Beija M, Afonso CAM, Martinho JMG. Synthesis and applications of Rhodamine derivatives as fluorescent probes. Chem Soc Rev 2009;38:2410–33.
   PubMed Web of Science ®Google Scholar
• Zhang J, Mi Q, Shen M. Resveratrol binding to collagen and its biological implication. Food Chem 2012;131:879–84.
   Web of Science ®Google Scholar
• Graf N, Lippitz A, Gross T, et al. Determination of accessible amino groups on surfaces by chemical derivatization with 3,5-bis(trifluoromethyl)phenyl isothiocyanate and XPS/NEXAFS analysis. Anal Bioanal Chem 2010;396:725–38.
   PubMed Web of Science ®Google Scholar
• Giebler R, Schulz B, Reiche J, et al. Near-edge X-ray absorption fine structure spectroscopy on ordered films of an amphiphilic derivate of 2,5-diphenyl-1,3,4-oxadiazole. Langmuir 1999;15:1291–8.
   Web of Science ®Google Scholar
• Liu Q, Chen J, Qin Y, et al. Zein/fucoidan-based composite nanoparticles for the encapsulation of pterostilbene: preparation, characterization, physicochemical stability, and formation mechanism. Int J Biol Macromol 2020;158:461–70.
   PubMed Web of Science ®Google Scholar
• Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 2010;8:31.
   PubMed Web of Science ®Google Scholar
• Yan W, Ren D, Feng X, et al. Neuroprotective and anti-inflammatory effect of pterostilbene against cerebral ischemia/reperfusion injury via suppression of COX-2. Front Pharmacol. 2021;12:770329.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang X, Ma A, et al. Orally administrated pterostilbene attenuates acute cerebral ischemia–reperfusion injury in a dose- and time-dependent manner in mice. Pharmacol Biochem Behav 2015;135:199–209.
   PubMed Web of Science ®Google Scholar
• Cipolletti M, Montalesi E, Nuzzo MT, et al. Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway: CIPOLLETTI et al. J Cell Physiol 2019;234:3147–57.
   PubMed Web of Science ®Google Scholar
• Fiocchetti M, Cracco P, Montalesi E, et al. Neuroglobin and mitochondria: the impact on neurodegenerative diseases. Arch Biochem Biophys 2021;701:108823.
   PubMed Web of Science ®Google Scholar
• Robb EL, Stuart JA. The stilbenes resveratrol, pterostilbene and piceid affect growth and stress resistance in mammalian cells via a mechanism requiring estrogen receptor beta and the induction of Mn-superoxide dismutase. Phytochemistry 2014;98:164–73.
   PubMed Web of Science ®Google Scholar
• Fratoddi I, Venditti I, Battocchio C, et al. Highly hydrophilic gold nanoparticles as carrier for anticancer copper(I) complexes: loading and release studies for biomedical applications. Nanomaterials 2019;9:772.
   Web of Science ®Google Scholar